A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma

Clinical trial NCT04379167 · UNKNOWN

Trial details

NCT number: NCT04379167
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2020-12-30
Primary completion: 2022-12-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.